Colorectal Cancer Screening

Colorectal Cancer Screening

Apply to Clinical Trial

CONTACT
Screening+of+Colorectal+Cancer

The study is designed to prospectively collect peripheral blood samples, general medical information including demographic and medical history as well as cancer screening outcomes and any cancer diagnosis confirmed during your study participation.

This information will be used to further develop and evaluate content, methodology, specimen processing and quality control for test application in cancer screening.

Peripheral blood samples will be collected from individuals presenting for their routine colonoscopy-based colorectal cancer (CRC) screening.

The blood samples and subject data will be used for the development of cancer screening and detection products, including for lung cancer and CRC for which there are established screening methods, and select other cancer types with no widely adopted standard screening in asymptomatic individuals: including but not limited to ovarian, pancreatic, stomach, bladder, or liver cancer.

CLINICAL TRIAL COLORECTAL CANCER

The study will be done based of the procedures in the protocol also depending at each visit some procedures might be different.

Patients can call office , request more info on our research website where we will then do a phone screen to prequalify subject for trial. That is when we will set patient up with an office appointment.

Cirrhosis is a condition in which scar tissue gradually replaces your healthy liver cells. Ulcerative colitis (UC) is a chronic condition that happens when you have inflammation in your colon.

Site will have to first prescreen subject to see what applies and what does not patients will also do a screening visit which will determine eligibility.

Share by: